Capital Research Global Investors Purchases 194,895 Shares of Integer Holdings Co. (NYSE:ITGR)

Capital Research Global Investors raised its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 16.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,410,803 shares of the medical equipment provider’s stock after acquiring an additional 194,895 shares during the quarter. Capital Research Global Investors’ holdings in Integer were worth $186,960,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. KBC Group NV increased its position in shares of Integer by 83.3% during the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock worth $212,000 after purchasing an additional 726 shares during the last quarter. Versant Capital Management Inc increased its holdings in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 183 shares during the last quarter. Lord Abbett & CO. LLC raised its position in Integer by 3.5% during the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock worth $37,716,000 after acquiring an additional 9,754 shares in the last quarter. Tributary Capital Management LLC raised its position in Integer by 0.8% during the fourth quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider’s stock worth $38,103,000 after acquiring an additional 2,289 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its stake in Integer by 3.9% in the fourth quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider’s stock valued at $24,154,000 after acquiring an additional 6,905 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ITGR. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Raymond James began coverage on Integer in a research note on Friday, March 28th. They issued an “outperform” rating and a $145.00 price objective on the stock. Truist Financial reduced their target price on Integer from $163.00 to $140.00 and set a “buy” rating for the company in a research note on Friday, April 11th. KeyCorp increased their price target on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Benchmark lifted their price objective on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $146.00.

Integer Price Performance

Shares of Integer stock opened at $116.99 on Monday. The company has a 50-day simple moving average of $121.57 and a two-hundred day simple moving average of $130.60. Integer Holdings Co. has a twelve month low of $104.93 and a twelve month high of $146.36. The stock has a market capitalization of $4.08 billion, a price-to-earnings ratio of 34.82, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.